MARKER THERAPEUTICS, INC. (MRKR) Net margin 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) net profit margin by fiscal year — reported net income divided by reported revenue.
-343.0%FY2025 · since FY2017: -5999.1% → -343.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -343.0% | -180.1 pp |
| FY2024 | -162.8% | +85.9 pp |
| FY2023 | -248.8% | +603.1 pp |
| FY2022 | -851.9% | — |
| FY2020 | -5741.2% | +4309.7 pp |
| FY2019 | -10050.9% | +61775.4 pp |
| FY2018 | -71826.3% | -65827.2 pp |
| FY2017 | -5999.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice